Mo1517 EVALUATION OF TRANSMURAL HEALING IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE SHOWS EARLY EFFICACY OF VEDOLIZUMAB: VECTORS WEEK 14 INTERIM ANALYSIS
Vipul Jairath, Rune Wilkens(Bispebjerg Hospital), Christian Agboton, Kerri L. Novak(University of Calgary), Yoon‐Kyo An(Mater Hospital), Blue Neustifter, Jingyang J. Wu(Takeda (United States)), GY Zou, Jeanne Jiang, Brian G. Feagan, I Romo Bautista, Silvio Danese, Marcelo Freire, Sudheer K. Vuyyuru, David T. Rubin, Remo Panaccione, Miles Sparrow, Aviv Pudipeddi, Christian Maaser, Mariangela Allocca, Jakob Begun, Bruce E. Sands, Krisztina Gecse, Marla C. Dubinsky, Robert V. Bryant(Queen Elizabeth Hospital), Christopher Ma, Stuart A. Taylor(Brighton and Sussex Medical School)
Cited by 0
Related Papers
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis
|Inflammatory Bowel Diseases|2019|94
Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients
|The Journal of Infectious Diseases|2023|77
Adhesion formation after previous caesarean section-a meta-analysis and systematic review
|BJOG An International Journal of Obstetrics & Gynaecology|2010|73